Ipca Laboratories to acquire 26.574% stake in Lyka Labs

Ipca Laboratories' board approved the acquisition of a 26.574% stake in Lyka Labs for Rs 97.89 crore, along with a joint management control agreement with Lyka Labs' promoters.

“Ipca Laboratories on Wednesday said that its board of directors has approved the acquisition of 26.574% of the paid-up share capital of Lyka Labs for a cash consideration of Rs 97.89 crore.”business-standard.com

• 1 source
• business-standard.comIpca Labs' board approves acquisition of over 26% stake in Lyka LabsBusiness StandardNov 24, 2021

Summarized from public sources; check the original articles before acting on it.